Novel macrocyclic inhibitors of hepatitus C virus replication

摘要

Disclosed are compounds of formula (Ia), (Ib), (Ic) and (Id) wherein the substituents are as defined in the specification.  The compounds are useful in the treatment of Hepatitis C virus infection.